Page last updated: 2024-08-22

trimetazidine and Labyrinth Diseases

trimetazidine has been researched along with Labyrinth Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wayoff, M1
D'Hooge, D; Kluyskens, P; Lambert, P1

Trials

2 trial(s) available for trimetazidine and Labyrinth Diseases

ArticleYear
[Evaluation of the therapeutic efficacy of vastarel 20 mg (trimetazidine) in cochleovestibular syndromes. A double-blind study versus placebo].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 1984, Volume: 101, Issue:7

    Topics: Adult; Audiometry; Clinical Trials as Topic; Cochlea; Double-Blind Method; Female; Humans; Labyrinth Diseases; Male; Middle Aged; Piperazines; Placebos; Random Allocation; Trimetazidine; Vestibular Function Tests; Vestibule, Labyrinth

1984
[Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 1990, Volume: 107 Suppl 1

    Topics: Adult; Analysis of Variance; Audiometry; Betahistine; Double-Blind Method; Female; Humans; Labyrinth Diseases; Male; Meniere Disease; Middle Aged; Time Factors; Trimetazidine; Vertigo; Vestibular Diseases

1990